The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| HM6A | N/A | N/A | N/A | N/A |
| S&P | +17.71% | +82.14% | +12.73% | N/A |
Hypera SA is a pharmaceutical company, which engages in the manufacture and distribution of medical and cosmetics products. Its products include foods and sweeteners; over-the-counter medication; prescribed medication; and dermocosmetics. The company was founded on December 1, 2001 and is headquartered in Sao Paulo, Brazil.
No news articles found for Hypera.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $349.81M | 11.2% |
| Gross Profit | $206.14M | 13.9% |
| Gross Margin | 58.93% | 1.4% |
| Market Cap | $1.95B | -22.2% |
| Net Income | $71.29M | 17.3% |
| EBITDA | $117.71M | 38.8% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $297.84M | -43.6% |
| Accounts Receivable | $254.55M | -48.3% |
| Inventory | 340.3 | 7.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $1.21B | -13.1% |
| Short Term Debt | $283.49M | -15.1% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 2.76% | -2.9% |
| Return On Invested Capital | 9.02% | -1.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $87.10M | 14.3% |
| Operating Free Cash Flow | $103.59M | 11.3% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 7.60 | 14.13 | 22.78 | 17.92 | 83.39% |
| Price to Book | 0.73 | 0.90 | 1.19 | 1.04 | -16.11% |
| Price to Sales | 1.42 | 1.75 | 2.54 | 2.10 | 5.87% |
| Price to Tangible Book Value | 16.59 | 35.52 | -166.96 | 134.30 | 271.16% |
| Price to Free Cash Flow TTM | 78.27 | 44.45 | 641.95 | 156.35 | 811.26% |
| Enterprise Value to EBITDA | 145.97 | -150.77 | 35.85 | 29.77 | -36.09% |
| Free Cash Flow Yield | 1.3% | 2.2% | 0.2% | 0.6% | -89.03% |
| Return on Equity | 11.7% | 6.9% | 6.1% | 6.5% | -51.97% |
| Total Debt | $1.50B | $1.54B | $1.41B | $1.49B | -13.51% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
